-
Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China
Mar 10, 2025, 14:00 PM -
Development of Hungarian One-Day Surgical Care in the Public-Funded National Healthcare System From 2010 to 2023
Mar 10, 2025, 14:00 PM -
Real-World Evidence on Health-Related Quality of Life in Older Women With Advanced Breast Cancer Treated With CDK 4/6 Inhibitors
Mar 10, 2025, 14:00 PM -
Epidemiology of Polymyalgia Rheumatica: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Burden of Illness in CIDP: Results of a Multinational Real-World Survey
Mar 10, 2025, 14:00 PM -
Robotic-Assisted Cholecystectomy Using the da Vinci Surgical Systems Compared to Laparoscopic or Open Approach - A Systematic Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D
Mar 10, 2025, 14:00 PM -
Patient-Provider Herpes Zoster Vaccination Discussion: Insights From Observed Primary Care Visits in the United States
Mar 10, 2025, 14:00 PM -
Predictive Modeling for Designing a Personalized Statin Therapy: Optimizing Treatment Efficacy in Cardiovascular Disease Prevention
Mar 10, 2025, 14:00 PM -
Exploring the Broader Societal Value of Pembrolizumab in Triple-Negative Breast Cancer and Cervical Cancer in Brazil
Mar 10, 2025, 14:00 PM -
Validation Evidence of Self-Reported Measures for Healthcare Resource Utilization in Adult Populations: A Systematic Review
Mar 10, 2025, 14:00 PM -
Development and Validation of a Machine Learning-based screening Algorithm to Predict High Risk of Hepatitis C Infection
Mar 10, 2025, 14:00 PM -
Utilization of Overall Survival and Other Survival Endpoints in Clinical Trials for Adjuvant Therapies in Resectable Tumors
Mar 10, 2025, 14:00 PM -
Disease Burden Estimates in Economic Evaluation Studies of Respiratory Syncytial Virus (RSV) Maternal Immunization: A Systematic Review
Mar 10, 2025, 14:00 PM -
Healthcare Resource Optimization of Different Formulations: Daratumumab SC Compared To Daratumumab IV for Treating Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Tisagenlecleucel for Third-Line Treatment With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
Mar 10, 2025, 14:00 PM -
Emerging Trends in List Price Adjustment Strategies Following Implementation of the Inflation Reduction Act
Mar 10, 2025, 14:00 PM -
Costs of Type 1 Diabetes Acute and Chronic Complications in Brazil Private Healthcare System
Mar 10, 2025, 14:00 PM -
Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade
Mar 10, 2025, 14:00 PM -
A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals
Mar 10, 2025, 14:00 PM
